Drug Channels
Pages
(Move to ...)
ABOUT
INDUSTRY REPORTS
WEBINARS
KEYNOTE SPEAKING
ADVERTISE
SUBSCRIBE / CONTACT
▼
Tuesday, November 23, 2021
Drug Channels News Roundup, November 2021: Health Plans and Insulin, Gross-to-Net Bubble Update, CVS & 340B, and Amazon Redux
›
Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. In this...
Friday, November 19, 2021
Pathway or Perish: The Two-Pronged Hurdle to Ensuring Access in Oncology
›
Today’s guest post comes from Carolyn Zele, Senior Manager of Solution Enablement at MMIT. Carolyn describes how oncology pathways were de...
Thursday, November 18, 2021
Small Pharmacies Continue to Run Away from Medicare Part D’s Preferred Networks
›
In my previous post , I highlighted the largest pharmacy chains that will participate in the 2022 Medicare Part D prescription drug plans (P...
Tuesday, November 16, 2021
CVS, Walgreens, Walmart, and Supermarkets Keep Position in 2022 Part D Preferred Networks—With a Little Help from 340B
›
In Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans , I highlighted how those networks have hijacked the world ...
Monday, November 15, 2021
Drug Channels Outlook 2022 (NEW Live Video Webinar)
›
Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webina...
Tuesday, November 09, 2021
Why PBMs and Payers Are Embracing Insulin Biosimilars with Higher Prices—And What That Means for Humira
›
The Food & Drug Administration (FDA) recently approved the first interchangeable biosimilar insulin product: the insulin glargine-yfgn i...
Monday, November 08, 2021
Informa Connect’s Trade & Channel Strategies
›
Informa Connect’s Trade & Channel Strategies Delivered as a Hybrid Event In-Person: December 13-14, 2021, Hilton Philadelphia at Penn’...
Friday, November 05, 2021
Risk-Based Cancer Care: A Specialty Pharmacy’s Role
›
Today’s guest post comes from Ashleigh Burdette, Senior Director of Clinical Innovation at Biologics by McKesson. Ashleigh explains how bi...
Tuesday, November 02, 2021
Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More
›
Open enrollment is under way for the 2022 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS...
Friday, October 29, 2021
Sophia’s Story: Student, Daughter, Marketing Professional, Person Living with Crohn’s
›
Today’s guest post comes from Megan Marchal, Clinical Pharmacist at CoverMyMeds. Megan shares the story of Sophia Garland, a young profess...
Thursday, October 28, 2021
Drug Channels News Roundup, October 2021: PBMs’ Oncology Exclusions, Biosimilar Boom, BCBS vs. Hospitals, U.S. vs. the World, and CRISPR Comedy
›
Fortunately, Halloween can’t be scarier than any other day this year. So grab your pillow case and stuff it with treats from the great Drug ...
Tuesday, October 26, 2021
Follow the Vial: The Buy-and-Bill System for Distributing and Reimbursing Provider-Administered Outpatient Drugs
›
By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. This chart c...
‹
›
Home
View web version